bpc-157 human clinical evidence safety fda warning trials review trial Peptides are having a moment. Influencers An FDA Reversal on Peptides BPC-157: Does It Work, and

The results mentioned are based on clinical experience and are not guaranteed

What they found: Favorable safety profile , no serious adverse events at doses up to 100 g/kg Preliminary efficacy signals positive The program stopped before Phase 3 for unknown commercial reasons (the program passed through several sponsor rotations and no one ultimately carried it through) Why it matters: These are the only published clinical data in humans that we have

Incorporate a B-12 injection into your regimen today to experience the energy and mood boost youve been longing for

doi: 10.3892/mmr.2017.7299 304 WooSJLeeSMLimHSHahYSJungIDParkYMet al

What differs is the recommended dose range and injection frequency